MedTrace Logo

Study of Copeptin as a Diagnostic Marker for Acute Pancreatitis

NCT01293318 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2016-10-25

No results posted yet for this study

Summary

The purpose of this study is to investigate if there is an association between copeptin level in serum and the severity of pancreatitis and if copeptin can be used as a predictor for organ failure and pancreatic necrosis with or without superinfection.

Conditions

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Christian A Nebiker, MD, Dr. · University Hospital, Basel, Switzerland

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2015-11-30
Completion
2016-09-30

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01293318 on ClinicalTrials.gov